0.015 (5.66%)
ASX:Live
Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
MQV
Very Strong
GARP
Very Strong
MQV Small
Neutral
Valuation
Value
Consensus
Momentum
Price
Very Strong
Earnings
Very Strong
Growth
Earnings
Very Strong
Dividends
Very Strong
Quality
Capital Efficiency
Very Strong
Balance Sheet
Very Strong
Telephone
61.3.8399.9419
Address
Level 3, Suite 69 574 Plummer Street Port Park-Building 2 Port Melbourne, Victoria (VIC) 3207
Description
Wellnex Life Ltd. engages in the provision of health and wellness products. It specializes in licensing and taking brands to the market in Australia and Asia. The company was founded by Lazarus Karasavvidis and Martin Glenister on May 6, 2011 and is headquartered in Port Melbourne, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.24 - 1.45
Trade Value (12mth)
AU$11,036.00
1 week
-11.67%
1 month
-10.17%
YTD
-55.69%
1 year
-70.76%
All time high
90.97
EPS 3 yr Growth
-79.30%
EBITDA Margin
-39.80%
Operating Cashflow
-$7m
Free Cash Flow Return
-203.30%
ROIC
-409.80%
Interest Coverage
-2.80
Quick Ratio
0.30
Shares on Issue (Fully Dilluted)
30m
HALO Sector
Staples
Next Company Report Date
29-Aug-25
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
| Date | Announcements |
|---|---|
|
06 May 25 |
Board and Management Changes
×
Board and Management Changes |
|
06 May 25 |
Final Director's Interest Notice
×
Final Director's Interest Notice |
|
14 April 25 |
Becoming a substantial holder
×
Becoming a substantial holder |
|
10 April 25 |
Appointment of Powermed Plus as UK Distributor
×
Appointment of Powermed Plus as UK Distributor |
|
08 April 25 |
Appendix 4C and Quarterly Report for Mar 2025 Quarter
×
Appendix 4C and Quarterly Report for Mar 2025 Quarter |
|
01 April 25 |
Change in substantial holding
×
Change in substantial holding |
|
01 April 25 |
Ceasing to be a substantial holder
×
Ceasing to be a substantial holder |
|
31 March 25 |
Application for quotation of securities - WNX
×
Application for quotation of securities - WNX |
|
28 March 25 |
Becoming a substantial holder
×
Becoming a substantial holder |
|
25 March 25 |
Application for quotation of securities - WNX
×
Application for quotation of securities - WNX |
|
25 March 25 |
Cleansing Notice
×
Cleansing Notice |
|
24 March 25 |
Commencement of Trading on LSE AIM
×
Commencement of Trading on LSE AIM |
|
24 March 25 |
Appendix 3X - Vivenne Zhang
×
Appendix 3X - Vivenne Zhang |
|
24 March 25 |
Appendix 3X - Ruari McGirr
×
Appendix 3X - Ruari McGirr |
|
21 March 25 |
Pain Away Deferred Consideration Fully Satisfied
×
Pain Away Deferred Consideration Fully Satisfied |
|
21 March 25 |
Application for quotation of securities - WNX
×
Application for quotation of securities - WNX |
|
21 March 25 |
Application for quotation of securities - WNX
×
Application for quotation of securities - WNX |
|
21 March 25 |
Admission Document for LSE AIM
×
Admission Document for LSE AIM |
|
19 March 25 |
Wellnex Publishes Admission Document to LSE AIM
×
Wellnex Publishes Admission Document to LSE AIM |
|
18 March 25 |
Trading Halt
×
Trading Halt |
|
14 March 25 |
Trading and UK IPO Update
×
Trading and UK IPO Update |
|
14 March 25 |
Application for quotation of securities - WNX
×
Application for quotation of securities - WNX |
|
14 March 25 |
Cleansing Notice
×
Cleansing Notice |
|
10 March 25 |
Appendix 3Y - George Karafotias Entitlement Offer
×
Appendix 3Y - George Karafotias Entitlement Offer |
|
10 March 25 |
Appendix 3Y - Zack Bozinovski Entitlement Offer
×
Appendix 3Y - Zack Bozinovski Entitlement Offer |
Load More
Load Less
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
.svg)
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.
